Literature DB >> 25805628

Imagery Rescripting for Obsessive Compulsive Disorder: A single case experimental design in 12 cases.

David Veale1, Nicholas Page2, Elizabeth Woodward2, Paul Salkovskis3.   

Abstract

BACKGROUND AND OBJECTIVES: Some individuals with Obsessive Compulsive Disorder (OCD) may experience recurrent intrusive distressing images, which may be emotionally linked to past aversive memories. Our aim was to investigate whether Imagery Rescripting was an effective intervention for such individuals with OCD.
METHOD: Twelve cases who experienced intrusive distressing images are presented in a A1BA2CA3 single case experimental design. After a baseline of symptom monitoring (A1), participants had a control intervention of talking about the memory related image (B), followed by symptom monitoring (A2), a single session of Imagery Rescripting (C) and further monitoring for up to 3 months (A3).
RESULTS: Minimal change was seen following the control intervention. However, at 3 months following ImRs, there was a drop in the Yale-Brown Obsessive Compulsive Scale, with a decrease from a mean of 24.1 to 10.7. Reliable improvement was achieved in 9 out of the 12 cases and clinically significant change in 7 out of 12 at 3-month follow up. The limitations are that all cases were selected on the basis that they had an aversive memory linked to their imagery.
CONCLUSIONS: Imagery Rescripting is a promising therapeutic technique for OCD as an adjunct to CBT where intrusive images are linked to aversive memories.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Imagery; Imagery Rescripting; Obsessive Compulsive Disorder; Traumatic memories

Mesh:

Year:  2015        PMID: 25805628     DOI: 10.1016/j.jbtep.2015.03.003

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  7 in total

1.  When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence.

Authors:  Brittany Mutsaers; Georden Jones; Nicole Rutkowski; Christina Tomei; Caroline Séguin Leclair; Danielle Petricone-Westwood; Sébastien Simard; Sophie Lebel
Journal:  Support Care Cancer       Date:  2016-05-12       Impact factor: 3.603

2.  Cognitive-Behavioral Treatment of Obsessive-Compulsive Disorder: The Results of a Naturalistic Outcomes Study.

Authors:  Andrea Gragnani; Vittoria Zaccari; Giuseppe Femia; Valerio Pellegrini; Katia Tenore; Stefania Fadda; Olga Ines Luppino; Barbara Basile; Teresa Cosentino; Claudia Perdighe; Giuseppe Romano; Angelo Maria Saliani; Francesco Mancini
Journal:  J Clin Med       Date:  2022-05-13       Impact factor: 4.964

3.  Short Imagery Rescripting Intervention to Treat Emotionally Dysregulated Behavior in Borderline Personality Disorder: An Exploratory Study.

Authors:  Caroline Schaitz; Julia Kroener; Anna Maier; Bernhard J Connemann; Zrinka Sosic-Vasic
Journal:  Front Psychiatry       Date:  2020-05-20       Impact factor: 4.157

4.  Impact of childhood maltreatment on obsessive-compulsive disorder symptom severity and treatment outcome.

Authors:  Sabrina Boger; Thomas Ehring; Götz Berberich; Gabriela G Werner
Journal:  Eur J Psychotraumatol       Date:  2020-06-08

Review 5.  Delivering Imagery Rescripting via Telehealth: Clinical Concerns, Benefits, and Recommendations.

Authors:  Georgie Paulik; Gayle Maloney; Arnoud Arntz; Nathan Bachrach; Annemieke Koppeschaar; Peter McEvoy
Journal:  Curr Psychiatry Rep       Date:  2021-03-16       Impact factor: 5.285

6.  Group Imagery Rescripting on Childhood Memories Delivered via Telehealth: A Preliminary Study.

Authors:  Katia Tenore; Alessandra Mancini; Olga Ines Luppino; Francesco Mancini
Journal:  Front Psychiatry       Date:  2022-06-23       Impact factor: 5.435

7.  Imagery Rescripting on Guilt-Inducing Memories in OCD: A Single Case Series Study.

Authors:  Katia Tenore; Barbara Basile; Teresa Cosentino; Brunetto De Sanctis; Stefania Fadda; Giuseppe Femia; Andrea Gragnani; Olga I Luppino; Valerio Pellegrini; Claudia Perdighe; Giuseppe Romano; Angelo M Saliani; Francesco Mancini
Journal:  Front Psychiatry       Date:  2020-09-30       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.